A detailed history of Great West Life Assurance CO transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 17,374 shares of BCRX stock, worth $135,169. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,374
Previous 17,374 -0.0%
Holding current value
$135,169
Previous $88,000 22.73%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$4.98 - $6.77 $222,954 - $303,092
-44,770 Reduced 72.04%
17,374 $103,000
Q3 2023

Nov 14, 2023

BUY
$6.71 - $7.92 $135,629 - $160,086
20,213 Added 48.21%
62,144 $439,000
Q2 2023

Aug 10, 2023

BUY
$6.96 - $8.81 $24,547 - $31,072
3,527 Added 9.18%
41,931 $297,000
Q1 2023

May 12, 2023

BUY
$7.94 - $11.84 $224,567 - $334,870
28,283 Added 279.45%
38,404 $321,000
Q4 2022

Feb 10, 2023

BUY
$10.5 - $14.2 $13,482 - $18,232
1,284 Added 14.53%
10,121 $117,000
Q3 2022

Nov 01, 2022

BUY
$10.79 - $14.81 $95,351 - $130,875
8,837 New
8,837 $111,000
Q1 2022

May 12, 2022

SELL
$11.56 - $19.76 $13,791 - $23,573
-1,193 Reduced 11.89%
8,837 $153,000
Q2 2021

Aug 11, 2021

SELL
$9.5 - $17.24 $23,959 - $43,479
-2,522 Reduced 20.09%
10,030 $158,000
Q1 2021

May 17, 2021

BUY
$7.37 - $13.61 $25,684 - $47,430
3,485 Added 38.44%
12,552 $127,000
Q3 2020

Nov 17, 2020

BUY
$3.43 - $5.53 $31,099 - $50,140
9,067 New
9,067 $31,000
Q3 2020

Nov 13, 2020

SELL
$3.43 - $5.53 $31,099 - $50,140
-9,067 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$1.9 - $5.61 $3,782 - $11,169
1,991 Added 28.14%
9,067 $43,000
Q4 2019

Feb 11, 2020

BUY
$1.59 - $3.45 $11,250 - $24,412
7,076 New
7,076 $24,000
Q3 2019

Oct 25, 2019

SELL
$2.5 - $3.73 $33,340 - $49,743
-13,336 Closed
0 $0
Q1 2019

May 08, 2019

BUY
$7.38 - $9.72 $44,545 - $58,669
6,036 Added 82.68%
13,336 $108,000
Q3 2017

Nov 09, 2017

BUY
$4.1 - $5.97 $29,929 - $43,581
7,300
7,300 $38,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.45B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.